For decades, pediatric brain cancer has remained one of medicine’s toughest battles. While remarkable advances have improved survival rates for many childhood cancers, aggressive brain tumors continue to claim far too many young lives. Families often face devastating news after diagnosis because available treatments rarely offer lasting success. Surgery is frequently impossible when tumors develop …
For decades, the words “incurable cancer” have carried a heavy finality. They signal the moment when treatment options run out, when medicine shifts from fighting the disease to managing symptoms and time becomes painfully finite. For families facing aggressive blood cancers that resist every standard therapy, this moment often arrives far too soon. But a …
What if fighting cancer didn’t mean months of grueling hospital visits, weeks of waiting for lab results, and treatments that can cost more than a home? What if the body could be taught to heal itself not over time, but within hours? For decades, scientists have dreamed of turning the immune system into a precision …
A vaccine designed to help the body hunt down and destroy lung cancer cells has officially entered human trials, marking a major milestone in the fight against one of the deadliest diseases in the world. Researchers across seven countries have begun testing the treatment in patients, with hopes that it could dramatically improve survival rates and …
On a quiet afternoon in early March 2020, Vita Sara Blechner was at home in Oceanside, New York when a sudden, sharp pain spread across her back. At first, it felt like something minor. Maybe acid reflux, maybe stress. But within hours, that discomfort turned into something far more serious. At the hospital, scans revealed …
What if treating lung cancer one day felt less like enduring aggressive therapy and more like using a device that supports your breathing. That idea may sound distant, but researchers are now testing a gene therapy that is inhaled directly into the lungs. After early clinical results showed signs of tumor response in patients with …
Pancreatic cancer has long been one of the most difficult cancers to treat. Often diagnosed at a late stage and known for spreading early, it presents unique biological challenges that make standard therapies less effective. For decades, chemotherapy and surgery were the main options available. While they have saved lives, survival rates have remained modest …
When virologist Beata Halassy faced a third recurrence of breast cancer, she made a decision that defied standard medical protocols and terrified her colleagues. Unwilling to endure another round of chemotherapy, she turned to her own laboratory for a solution. Halassy cultivated specific viruses and injected them directly into her own tumor, becoming both the …
For decades, cancer treatment has followed a familiar pattern. First comes diagnosis, then a combination of surgery, radiation, chemotherapy, or targeted drugs, often customized to the molecular signature of a patient’s tumor. While this approach has saved many lives, it has also revealed a hard truth. Cancer, especially solid tumors like breast cancer, is remarkably …
Cancer vaccines have always come with a frustrating catch. Unlike flu shots that work for millions of people, most cancer vaccines need to be custom-made for each patient. Doctors must extract tumor samples, analyze them, and build a vaccine tailored to that specific person’s cancer. By the time all that happens, months have passed, and …
The syringe contained no poison to kill cancer cells, no radioactive particles to burn through tissue, no harsh chemicals to ravage a patient’s body. Instead, it held something far more revolutionary: a set of molecular instructions that would transform a 67-year-old scientist’s immune system into a personalized cancer-hunting army. Janusz Racz didn’t know it as …
When millions lined up for COVID-19 vaccines during the pandemic, survival meant avoiding a deadly virus. Few could have imagined that same shot might offer protection against something else entirely. Researchers at two major cancer centers have stumbled onto a finding that could reshape how oncologists treat advanced disease. Patients with late-stage lung and skin …